Evidence map›Paper›PMID 25512609›Full record

ArticleMolecular and cellular biology2015

TORC1 inhibition induces lipid droplet replenishment in yeast.

Juliana B Madeira, Claudio A Masuda, Clarissa M Maya-Monteiro, Gabriel Soares Matos, Mónica Montero-Lomelí, Bruno L Bozaquel-Morais

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Kog1 Represses Lipid Accumulation inJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Microbiology spectrum · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Microbiology spectrum · 2022
    Article
  15. Article
  16. Article
  17. The Unicellular Red AlgaPlants (Basel, Switzerland) · 2021
    Review
  18. Article
  19. Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions.Frontiers in cell and developmental biology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Juliana B MadeiraInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Claudio A MasudaInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Clarissa M Maya-MonteiroLaboratório de Imunofarmacologia, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, Brazil.
Gabriel Soares MatosInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Mónica Montero-LomelíInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil montero@bioqmed.ufrj.br.
Bruno L Bozaquel-MoraisInstituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRFundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid droplets (LDs) are intracellular structures that regulate neutral lipid homeostasis. In mammals, LD synthesis is inhibited by rapamycin, a known inhibitor of the mTORC1 pathway. In Saccharomyces cerevisiae, LD dynamics are modulated by the growth phase; however, the regulatory pathways involved are unknown. Therefore, we decided to study the role of the TORC1 pathway on LD metabolism in S. cerevisiae. Interestingly, rapamycin treatment resulted in a fast LD replenishment and growth inhibition. The discovery that osmotic stress (1 M sorbitol) also induced LD synthesis but not growth inhibition suggested that the induction of LDs in yeast is not a secondary response to reduced growth. The induction of LDs by rapamycin was due to increased triacylglycerol but not sterol ester synthesis. Induction was dependent on the TOR downstream effectors, the PP2A-related phosphatase Sit4p and the regulatory protein Tap42p. The TORC1-controlled transcriptional activators Gln3p, Gat1p, Rtg1p, and Rtg3p, but not Msn2p and Msn4p, were required for full induction of LDs by rapamycin. Furthermore, we show that the deletion of Gln3p and Gat1p transcription factors, which are activated in response to nitrogen availability, led to abnormal LD dynamics. These results reveal that the TORC1 pathway is involved in neutral lipid homeostasis in yeast.

Indexed as

Gene Expression Regulation, FungalAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCholesterol EstersGATA Transcription FactorsLipid DropletsLipid MetabolismOsmotic PressurePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Phosphatase 2Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionSirolimusSorbitolAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCholesterol EstersGAT1 protein, S cerevisiaeGATA Transcription FactorsGLN3 protein, S cerevisiaePhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProtein Phosphatase 2RTG1 protein, S cerevisiaeRTG3 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSirolimusSIT4 protein, S cerevisiaeSorbitolTAP42 protein, S cerevisiaeTOR1 protein, S cerevisiaeTORC1 protein complex, S cerevisiaeTranscription FactorsTriglycerides

Identifiers

PMID25512609
PMCPMC4301715
OpenAlexW2100396278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.